Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,830.00    -26.00 (-1.40%)
Bid:
1,825.00
Ask:
1,828.00
Spread: 3.00 (0.164%)
Market Cap: £3.59b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Directorate Change

15 Oct 2008 13:51

RNS Number : 9186F
Screen Technology Group plc
15 October 2008
 



15 October 2008

Screen Technology Group plc

("Screen Technology" or the "Company")

Directorate Change

Screen Technology announces that Tom Jarman has stepped down as Chief Executive Officer. Tom has been succeeded by Chris Hanson, Screen Technology's CFO, who has today been appointed a director of the Company.

Tom has agreed to remain an employee of the Group until early 2009 to ensure a smooth transition.

Tom has been a director of Screen Technology for almost seven years and has been CEO since 2006, during which time he has made a significant contribution to the business. Tom wishes to spend more time with his family in Gloucestershire and he and the Board agreed that it is the right time for new leadership to take the business forward.

David Christopher Hanson (50) has been Screen Technology's CFO since June 2007. Chris was previously Finance Director and then Chief Operating Officer at Cardpoint plc. He has extensive experience as a Finance Director with a number of other public companies including Parkland Group plc and JWE Telecom plc. He qualified as an accountant in 1982 and spent 13 years with KPMG.

Chris has a beneficial and family interest in 3,181,818 Screen Technology ordinary shares representing approximately 1.56 per cent of the share capital of the Company. He also has warrants to acquire a further 11,484,848 Screen Technology ordinary shares at a price of 0.66 per share.

The Board is also pleased to announce two new appointments to the Board of Screen Technology Limited, the Company's main trading subsidiary. Campbell Cromar has been appointed as Managing Director and Paul Bayley as Sales Director. Campbell is currently Chief Operating Officer of Screen Technology Limited and has 22 years experience in the digital screen market. Paul, a founder member of the Itrans team, has been with the business for 12 years and was previously Chief Technology Officer. 

Peter Smyth, Screen Technology Chairman, commented, "I would like to thank Tom for his contribution, particularly during the refinancing which took place earlier this year, and I am pleased to announce Chris as his successor. I am also very pleased to announce the changes that we have made at Screen Technology Limited which I believe will allow the business to build on the progress made to date."

Screen Technology Group plc

Peter Smyth

Chris Hanson

Tel: 01353 660250

Charles Stanley Securities 

Nominated Adviser

Russell Cook / Carl Holmes

Tel: 020 7149 6000

Chris Hanson Current Directorships

None

Chris Hanson Previous Directorships

Pharmetiq plc

Cardpoint plc

Chris Hanson was a director of John Brunton plc when it was placed into administrative receivership in July 1993. He was initially seconded from KPMG to John Brunton plc and later became a director, with a view to assisting with a turn around of the business. When it became apparent that this was not possible, John Brunton plc was placed into administrative receivership owing approximately £935,000.

There are no other details required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGUAUUPRGPA
Date   Source Headline
28th Mar 20185:53 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHalf-year Report
9th Mar 20183:48 pmRNSDirector/PDMR Shareholding
9th Feb 20183:28 pmRNSDirector/PDMR Shareholding
6th Feb 20187:00 amRNSPre Interim Results Trading Update
10th Jan 20182:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:39 pmRNSDirector/PDMR Shareholding
12th Dec 20175:47 pmRNSHolding(s) in Company
12th Dec 20175:34 pmRNSHolding(s) in Company
11th Dec 201711:22 amRNSDirector/PDMR Shareholding
8th Dec 20174:21 pmRNSTotal Voting Rights
8th Dec 20174:21 pmRNSResult of AGM
30th Nov 20175:26 pmRNSDirector/PDMR Shareholding
30th Nov 20175:25 pmRNSDirector/PDMR Shareholding
29th Nov 20177:00 amRNSQ1 2018 Trading Update
16th Nov 20174:24 pmRNSReplacement - Director/PDMR Shareholding
16th Nov 20174:08 pmRNSDirector/PDMR Shareholding
15th Nov 20179:36 amRNSHolding(s) in Company
13th Nov 20177:00 amRNSGraeme Watt to be appointed as new CEO
9th Nov 20173:01 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:09 pmRNSAnnual Financial Report
31st Oct 20177:00 amRNSAdditional Listing
18th Oct 20177:00 amRNSFinal Results
10th Oct 20173:04 pmRNSDirector/PDMR Shareholding
4th Oct 20174:33 pmRNSHolding(s) in Company
18th Sep 20179:00 amRNSNotice of Results
12th Sep 20172:23 pmRNSDirector/PDMR Shareholding
10th Aug 20174:24 pmRNSDirector/PDMR Shareholding
25th Jul 20173:23 pmRNSDirector/PDMR Shareholding
11th Jul 20174:31 pmRNSDirector/PDMR Shareholding
9th Jun 201711:08 amRNSDirector/PDMR Shareholding
26th May 20172:31 pmRNSHolding(s) in Company
24th May 20177:00 amRNSBoard Changes
24th May 20177:00 amRNSQ3 2017 Trading Update
11th May 20171:15 pmRNSDirector/PDMR Shareholding
8th May 20174:46 pmRNSHolding(s) in Company
28th Apr 201711:40 amRNSDirector/PDMR Shareholding
11th Apr 20174:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20177:00 amRNSHalf-year Report
9th Mar 20172:45 pmRNSDirector/PDMR Shareholding
20th Feb 201710:00 amRNSNotice of Results
10th Feb 20179:57 amRNSDirector/PDMR Shareholding
12th Jan 20173:08 pmRNSDirector/PDMR Shareholding
4th Jan 20174:55 pmRNSDirectorate Change
13th Dec 201610:26 amRNSDirector/PDMR Shareholding
8th Dec 20165:42 pmRNSResult of AGM
8th Dec 20165:35 pmRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSQ1 2017 Trading Update
16th Nov 20165:52 pmRNSDirector/PDMR Shareholding
10th Nov 20169:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.